Siobhan Fleming, business development manager at Siemens, discusses how and why biopharma companies can benefit from data analytics. Is it time for biopharma to follow in the footsteps of sectors such as telecoms, advertising and insurance in embracing data analytics?
We spoke to Siemens business development manager Siobhan Fleming to learn more. Can you explain what your current job involves? I joined Siemens Digital Industries in March this year to manage the business development activities for BioMAC. BioMAC is our advanced big data analytics solution for biopharma – it is supported by the IDA and has been developed in collaboration with the National Institute for Bioprocessing Research and Training (NIBRT).